Carnegie Lake Advisors LLC lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 94.0% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,468 shares of the healthcare conglomerate's stock after selling 22,978 shares during the quarter. UnitedHealth Group comprises 0.5% of Carnegie Lake Advisors LLC's portfolio, making the stock its 25th largest position. Carnegie Lake Advisors LLC's holdings in UnitedHealth Group were worth $539,000 as of its most recent SEC filing.
Several other large investors have also recently made changes to their positions in the business. BlackRock Inc. increased its position in UnitedHealth Group by 4.6% during the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate's stock valued at $31,946,594,000 after buying an additional 3,395,530 shares in the last quarter. State Street Corp grew its stake in shares of UnitedHealth Group by 0.7% in the second quarter. State Street Corp now owns 45,633,267 shares of the healthcare conglomerate's stock worth $18,966,555,000 after acquiring an additional 301,081 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in shares of UnitedHealth Group by 6.1% during the second quarter. Bank of New York Mellon Corp now owns 10,704,994 shares of the healthcare conglomerate's stock valued at $4,449,317,000 after acquiring an additional 616,723 shares in the last quarter. Wellington Management Group LLP increased its holdings in shares of UnitedHealth Group by 5.8% during the second quarter. Wellington Management Group LLP now owns 10,675,175 shares of the healthcare conglomerate's stock valued at $4,436,923,000 after acquiring an additional 583,536 shares in the last quarter. Finally, Corient Private Wealth LP raised its position in shares of UnitedHealth Group by 1,443.7% in the 2nd quarter. Corient Private Wealth LP now owns 8,447,224 shares of the healthcare conglomerate's stock worth $3,510,920,000 after purchasing an additional 7,900,011 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
UnitedHealth Group Trading Down 0.0%
Shares of NYSE:UNH opened at $394.14 on Monday. The stock's 50-day simple moving average is $390.62 and its two-hundred day simple moving average is $364.03. The stock has a market capitalization of $353.16 billion, a price-to-earnings ratio of 22.51, a PEG ratio of 1.43 and a beta of 0.51. UnitedHealth Group Incorporated has a 52-week low of $255.96 and a 52-week high of $461.62. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.74 and a current ratio of 0.74.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The company had revenue of $112.72 billion for the quarter, compared to the consensus estimate of $111.31 billion. During the same quarter last year, the firm posted $2.59 earnings per share. The firm's revenue was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Analysts expect that UnitedHealth Group Incorporated will post 20.61 EPS for the current year.
UnitedHealth Group Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, December 7th will be given a $2.32 dividend. The ex-dividend date is Monday, December 7th. This represents a $9.28 dividend on an annualized basis and a yield of 2.4%. UnitedHealth Group's dividend payout ratio is presently 53.00%.
Insider Activity at UnitedHealth Group
In other news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the transaction, the chief executive officer directly owned 15,328 shares of the company's stock, valued at $5,977,920. The trade was a 7.09% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.19% of the stock is owned by company insiders.
Wall Street Analyst Weigh In
A number of equities analysts recently issued reports on the stock. Stephens set a $500.00 price target on shares of UnitedHealth Group in a research note on Friday, October 16th. Raymond James Financial restated an "outperform" rating and set a $450.00 price objective on shares of UnitedHealth Group in a research note on Thursday, October 15th. Morgan Stanley upped their target price on shares of UnitedHealth Group from $529.00 to $531.00 and gave the stock an "overweight" rating in a research note on Tuesday, October 27th. TD Cowen reiterated a "hold" rating and set a $402.00 price target on shares of UnitedHealth Group in a report on Thursday, October 15th. Finally, Argus raised their price target on shares of UnitedHealth Group from $400.00 to $470.00 and gave the company a "buy" rating in a research report on Monday, July 20th. Twenty analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $463.93.
Get Our Latest Report on UnitedHealth Group
More UnitedHealth Group News
Here are the key news stories impacting UnitedHealth Group this week:
About UnitedHealth Group
(
Free Report)
UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid.
Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.
Founded in 1977 as United HealthCare Corporation, the company is headquartered in Minnetonka, Minnesota.
See Also
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.